Momentum Life Sciences Earns Dual Recognition as 2025 PM360 Trailblazer Awards Finalist

Momentum Life Sciences has been named a finalist in two categories at the 2025 PM360 Trailblazer Awards, which honor the most innovative and impactful initiatives in life sciences.

Our recognition spans two key areas where we help pharmaceutical manufacturers achieve meaningful outcomes: improving patient treatment adherence and delivering impactful educational experiences for healthcare providers. Both finalist programs demonstrate our ability to design patient-centric solutions that drive measurable results.

Our 2025 PM360 Trailblazer Award Finalist Categories:

  • Persistence/Adherence Program – showcasing our patient-centric approach to improving treatment outcomes
  • HCP Education – demonstrating our expertise in delivering engaging, evidence-based educational experiences
PM 360 Trailblazer Award Finalists in the Categories of Patient Adherence and HCP Education

These finalist nominations reflect our unwavering commitment to reimagining the patient experience through authentic engagement and seamless coordination. Our solutions draw on decades of expertise, blending real human connection with advanced digital technology, tailored to the needs of patients and healthcare providers.

This recognition affirms what we see every day: when patient support programs are built on partnerships that value human connection and coordinated touchpoints, remarkable outcomes follow.

This achievement belongs to our entire team and the clients who trust us to bring their patient support visions to life. These nominations validate our belief that excellence comes from putting patients and healthcare providers at the center of everything we do.

We’re honored to be recognized alongside the innovative organizations shaping the future of healthcare engagement.

Winners will be announced at the PM360 Trailblazer Awards ceremony. Follow our updates on LinkedIn as we celebrate this milestone with our team and clients.

About Momentum Life Sciences

Momentum Life Sciences is the leading provider of patient engagement solutions integrating human connection, advanced technology, and real-world data to deliver holistic support in a personalized environment. Leveraging 30 years of experience in patient engagement, our OneVoice™ model empowers biopharma teams to optimize the right mix of interventions for each patient.

Latest Press Relases

  • Momentum Life Sciences Named One of America’s Top 100 Most Loved Workplaces® for 2025 — Ranking #30

    Indianapolis, IN - October 21, 2025 - Momentum Life Sciences, a leader in patient engagement solutions, has been named one of the 2025 America’s Top 100 Most Loved Workplaces®, ranking #30 among companies nationwide.

  • Momentum Celebrates Winners of Premier Patient Support Awards: The GoMentum Awards 2025

    INDIANAPOLIS, IN – [October 8, 2025] – Momentum Life Sciences announces the winners of the premier Patient Support Awards, also known as the GoMentum Awards 2025. This inaugural program recognizes outstanding patient support initiatives that go above and beyond to create greater momentum for patients and providers across the life sciences industry.

  • Momentum Life Sciences Earns Dual Recognition as 2025 PM360 Trailblazer Awards Finalist

  • PM360 Magazine Names Jennifer Wagner of Momentum Life Sciences to 2025 Elite 100 for Transformational Leadership

    Indianapolis, Indiana – May 13, 2025 - Momentum Life Sciences proudly announces that Jennifer Wagner, Vice President of Client Solutions, has been selected for the prestigious 2025 Elite 100 by PM360 Magazine in the Transformational Leadership category for her exceptional impact on healthcare innovation and delivery.